Promoter polymorphisms and methylation of E-cadherin (CDH1) and KIT in gastric cancer patients from northern Brazil

Anticancer Res. 2010 Jun;30(6):2225-33.

Abstract

The aim of this study was to verify genetic and epigenetic alterations in gastric cancer patients from Pará state, northern Brazil.

Materials and methods: Exon 11 of KIT and two promoter polymorphisms (-160 C/A and -347 G/GA) of the E-cadherin gene (CDH1), and their correlation with the promoter methylation status were analyzed.

Results: No genetic alterations in KIT were found. Promoter polymorphisms revealed an increased probability of developing gastric cancer, especially of the diffuse-type, in patients carrying -160 A and -347 GA alleles. Analyses of CDH1 methylation suggested a significant difference between hypermethylated and non-hypermethylated samples, with a positive association between the -160 A allele and hypermethylation.

Conclusion: Our results suggest that -160 A and -347 GA polymorphisms may increase the chance of developing gastric cancer in the studied population and that -160 A polymorphism seems to be related to the hypermethylation pattern of the promoter region of CDH1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Cadherins / genetics*
  • CpG Islands
  • DNA Methylation*
  • Female
  • Gene Frequency
  • Haplotypes
  • Humans
  • Male
  • Middle Aged
  • Promoter Regions, Genetic*
  • Proto-Oncogene Proteins c-kit / genetics*
  • Stomach Neoplasms / genetics*

Substances

  • Cadherins
  • Proto-Oncogene Proteins c-kit